Atlas Trials

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Clinical trial NCT00105313 · TERMINATED

Trial details

NCT number
NCT00105313
Sponsor
MedImmune LLC
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
LymphomaLeukemiaCancer
Start date
2005-02-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.